Giant Biogene Holding Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	4,459	3,524	2,364	1,552	1,190	956.7
Revenue Growth (YoY)	49.36%	49.05%	52.30%	30.41%	24.44%	-
Cost of Revenue	769.5	577.01	369.21	198.15	183.41	159.99
Gross Profit	3,689	2,947	1,995	1,354	1,007	796.71
Selling, General & Admin	1,616	1,261	817.44	418.49	189.41	121.38
Research & Development	89.66	74.97	44.04	24.95	13.38	11.4
Other Operating Expenses	-	-	-	-	2	1.26
Operating Expenses	1,706	1,335	862.1	443.77	202.32	135.06
Operating Income	1,983	1,612	1,133	910.57	804.75	661.66
Interest Expense	-0.11	-0.11	-0.02	-	-	-
Interest & Investment Income	62.72	47.49	13.16	9.41	9.88	16.18
Currency Exchange Gain (Loss)	1.09	1.09	-14.45	21.61	-	-
Other Non Operating Income (Expenses)	43.07	55.58	54.2	16.86	3.83	9.12
EBT Excluding Unusual Items	2,090	1,716	1,186	958.44	818.46	686.95
Gain (Loss) on Sale of Investments	34.49	29.33	-8.28	14.47	154.78	0.16
Legal Settlements	-	-	-	-	-	-10.12
Pretax Income	2,125	1,745	1,178	972.92	973.24	677
Income Tax Expense	361.97	296.89	176.16	144.79	146.76	101.82
Earnings From Continuing Operations	1,763	1,448	1,002	828.13	826.49	575.18
Minority Interest in Earnings	5.25	3.55	0.44	-	-0.04	-22.92
Net Income	1,768	1,452	1,002	828.13	826.45	552.26
Preferred Dividends & Other Adjustments	-	-	306.03	19.32	-	-
Net Income to Common	1,768	1,452	696	808.81	826.45	552.26
Net Income Growth	43.54%	44.88%	21.00%	0.20%	49.65%	-
Shares Outstanding (Basic)	973	976	703	975	1,000	1,000
Shares Outstanding (Diluted)	986	983	1,021	1,001	1,000	1,000
Shares Change (YoY)	-1.01%	-3.77%	2.03%	0.09%	-	-
EPS (Basic)	1.82	1.49	0.99	0.83	0.83	0.55
EPS (Diluted)	1.80	1.48	0.98	0.83	0.83	0.55
EPS Growth	46.63%	50.83%	18.70%	0.03%	50.26%	-
Free Cash Flow	1,673	1,421	778.97	617.4	758.62	570.98
Free Cash Flow Per Share	1.70	1.45	0.76	0.62	0.76	0.57
Dividend Per Share	0.440	0.440	-	-	-	-
Gross Margin	82.74%	83.63%	84.39%	87.24%	84.59%	83.28%
Operating Margin	44.48%	45.73%	47.92%	58.65%	67.60%	69.16%
Profit Margin	39.65%	41.19%	29.44%	52.10%	69.42%	57.73%
Free Cash Flow Margin	37.51%	40.33%	32.95%	39.77%	63.72%	59.68%
EBITDA	2,019	1,643	1,159	933.64	826.02	678.83
EBITDA Margin	45.28%	46.63%	49.00%	60.14%	69.39%	70.96%
D&A For EBITDA	35.36	31.62	25.53	23.07	21.27	17.18
EBIT	1,983	1,612	1,133	910.57	804.75	661.66
EBIT Margin	44.48%	45.73%	47.92%	58.65%	67.60%	69.16%
Effective Tax Rate	17.04%	17.01%	14.96%	14.88%	15.08%	15.04%

Source: S&P Capital IQ. Standard template. Financial Sources.